A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2018-07-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of vilazodone
for the treatment of MDD in pediatric outpatients (7-17 years).